Biomea Fusion (BMEA) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Biomea Fusion (BMEA) has outperformed Stablecoin Development (SDEV) over the past year, losing 18.5% versus a loss of 66.8%. Over five years, BMEA leads with a -88.2% price change compared with -99.9% for SDEV. Stablecoin Development is the larger company by market cap ($103.0 million vs $99.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BMEA | SDEV |
|---|---|---|
| Share price | $1.37 | $1.99 |
| Market cap | $99.05M | $102.99M |
| 1-day change | +3.79% | -28.42% |
| YTD return | +10.48% | -92.94% |
| 1-year return | -18.45% | -66.83% |
| 5-year return | -88.22% | -99.94% |
| EPS (TTM) | $-0.29 | $-21.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.24 | $99.75 |
| 52-week low | $0.872 | $0.78 |
| Distance from 52-week high | -38.76% | -98.01% |
| Average volume | 1.47M | 11.42M |
| Shares outstanding | 72.30M | 51.75M |
| Employees | — | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BMEA has outperformed SDEV by 48.4 percentage points over the past year.
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
BMEA vs SDEV FAQ
Which is bigger, Biomea Fusion or Stablecoin Development?
Stablecoin Development (SDEV) is larger, with a market capitalization of $102.99M compared with $99.05M for Biomea Fusion (BMEA).
Which stock has performed better over the past year, BMEA or SDEV?
BMEA returned -18.45% over the past 12 months, compared with -66.83% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are Biomea Fusion and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.